Byron Robinson
2022
In 2022, Byron Robinson earned a total compensation of $3.4M as Chief Strategy Officer at Janux Therapeutics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $154,856 |
| Option Awards | $2,760,989 |
| Salary | $351,945 |
| Total | $3,367,790 |
Robinson received $2.8M in option awards, accounting for 82% of the total pay in 2022.
Robinson also received $100K in bonus, $154.9K in non-equity incentive plan and $351.9K in salary.
Rankings
In 2022, Byron Robinson's compensation ranked 1,072nd out of 5,760 executives tracked by ExecPay. In other words, Robinson earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,072 out of 5,760 | 81st |
Division Manufacturing | 504 out of 3,136 | 84th |
Major group Chemicals And Allied Products | 181 out of 1,422 | 87th |
Industry group Drugs | 162 out of 1,323 | 88th |
Industry Pharmaceutical Preparations | 120 out of 969 | 88th |
Source: SEC filing on April 28, 2023.
Robinson's colleagues
We found two more compensation records of executives who worked with Byron Robinson at Janux Therapeutics in 2022.